- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05652413
Engaging African American Older Adults With Arthritis in a Physical Activity Intervention
Enhancing Recruitment and Engagement of African American Older Adults With Osteoarthritis Pain in a Behavioral Pain Management and Physical Activity Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 65 or older
- English speaking
- identify as Black/African American
- diagnosis of osteoarthritis in knee or hip
- able to ambulate even if assisted with walker or cane
- endorse worst pain and pain interference as ≥ 3 out of 10 within the last week
Exclusion Criteria:
- hearing or visual impairment that would prevent ability to participate in sessions or use participant worksheets, even with use of adaptive supports/devices
- planned surgery during study duration that would limit mobility (e.g., due to recommended rehabilitation or recovery period) for more than 3 weeks
- current enrollment in cardiac rehabilitation
- myocardial infarction in the past 3 months
- major surgery requiring limited movement or mobility for recovery within the past 3 months
- presence of a serious psychiatric condition (e.g., schizophrenia, suicidal intent) that would contraindicate safe study participation
- Medical provider indicating that exercise (even walking) should only be medically supervised
- fall or falls within the last 3 months that led to immediate medical treatment/hospitalization
- reported or suspected moderate or severe cognitive impairment
- brain tumor/cancer metastases to the brain
- no other conditions that would preclude safe participation (e.g., unmanaged heart conditions, neurodegenerative condition, unmanaged diabetes, severe respiratory disease), as screened the Physical Activity Readiness Questionnaire (PAR-Q+ 2020, a measure widely utilized by the U.S. National Academy of Sports Medicine and the Public Health Agency of Canada). Answers to the PARQ+2020 may result in review by patient physicians for safety prior to enrollment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adapted-Engage-PA
Participants will receive two sessions, lasting 60 minutes each, of behavioral intervention strategies to increase daily walking routines and prevent pain flares.
|
Enhanced motivation strategies for increasing walking using personal values assessment and value-guided goal setting, adapted from Acceptance and Commitment therapy.
Strategic activity pacing to increase stamina and reduce pain flares when walking, using the Activity Rest Cycle, from Pain Coping Skills Training.
Culturally sensitive elements for older adults who identify as African American such as linking motivation to spirituality, family, community, and other personally-meaningful values.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of enrolled participants
Time Frame: 6 months
|
Did the study reach full anticipated accrual?
|
6 months
|
|
Number of participants who completed the entire program
Time Frame: 8 weeks
|
Participants who complete all assessments and required study sessions
|
8 weeks
|
|
Percentage of participants who were mostly or very satisfied with the intervention
Time Frame: Post-treatment (8 weeks)
|
Client Satisfaction Questionnaire asks 8 questions related to patient satisfaction on a Likert Scale of 1= very satisfied to 7 = very dissatisfied.
There is one item assessing overall satisfaction with the intervention, and the percentage of participants responding to this item with "mostly" or "very" satisfied is reported below.
|
Post-treatment (8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arthritis Pain (AIMS 2 Symptom Subscale)
Time Frame: Baseline, post-treatment (8 weeks)
|
The Arthritis Impact Measurement Scale (AIMS 2) measures arthritis pain related disability across areas of living both with a total score and on several subscales (i.e., pain severity, physical functioning/pain- related disability, psychological distress), where 1 indicates very good functioning, and 5 indicates very poor functioning.
Symptom subscale includes items assessing pain severity, stiffness, and physical discomfort.
Range is 5 to 25 where higher scores indicate worse functioning.
|
Baseline, post-treatment (8 weeks)
|
|
Arthritis-related Physical Functioning (AIMS 2 Physical Functioning Subscale)
Time Frame: Baseline, post-treatment (8 weeks)
|
The Arthritis Impact Measurement Scale (AIMS 2) measures arthritis pain related disability across areas of living on several subscales (i.e., pain severity, physical functioning/pain-related disability, psychological distress), where 1 indicates very good functioning, and 5 indicates very poor functioning.
Physical functioning subscale includes items assessing mobility level, walking and bending, self-care and household tasks.
Range is 5-25 where higher scores indicate worse functioning.
|
Baseline, post-treatment (8 weeks)
|
|
Psychological Distress (AIMS 2 Affect Subscale)
Time Frame: Baseline, post-treatment (8 weeks)
|
The Arthritis Impact Measurement Scale (AIMS 2) measures arthritis pain related disability across areas of living on several subscales (i.e., pain severity, physical functioning/pain-related disability, psychological distress), where 1 indicates very good functioning, and 5 indicates very poor functioning.
Psychological distress subscale includes items assessing mood and anxiety/tension.
Range is 5-25 where higher scores indicate worse functioning.
|
Baseline, post-treatment (8 weeks)
|
|
Step Count
Time Frame: Baseline, post-treatment (8 weeks)
|
Daily step counts as reported to study staff, after participants recorded them from wearable fitness trackers at end of day.
Each assessment period consisted of 7 continuous days of wear.
Summed totals of steps in the 7 day period were calculated, and then means calculated between groups of these summed step counts for the 7 day assessment period.
|
Baseline, post-treatment (8 weeks)
|
|
Rapid Assessment of Physical Activity
Time Frame: Baseline, post-treatment (8 weeks)
|
The RAPA is a self-reported measure that assesses participants engagement in a variety of activities, such as light movement, moderate activity, vigorous activity, and other activities such as strength-training or yoga.
Scores range from 0 - 7, where higher scores indicate greater involvement in physical activity overall.
|
Baseline, post-treatment (8 weeks)
|
|
Psychological Flexibility
Time Frame: Baseline, post-treatment (8 weeks)
|
The Acceptance and Action Questionnaire-II asks about psychological flexibility, defined as how often thoughts, feelings and body sensations get in the way of living a fulfilling life. Responses are on a 1 to 7 Likert scale with 1 indicating that these issues never get in the way, and 7 indicating that these issues always get in the way. Range is 7 - 49, with lower scores indicating better outcomes. Title: Psychological Flexibility The Acceptance and Action Questionnaire-II asks about psychological flexibility, defined as how often thoughts, feelings and body sensations get in the way of living a fulfilling life. Responses are on a 1 to 7 Likert scale with 1 indicating that these issues never get in the way, and 7 indicating that these issues always get in the way. Range is 7 - 49, with lower scores indicating better outcomes. |
Baseline, post-treatment (8 weeks)
|
|
Valued Living - Health Domain
Time Frame: Baseline, post-treatment (8 weeks)
|
The Bulls-Eye Values measure assesses how successfully participants are at living in line with 4 domains of personal values (relationships, leisure, health, and work) on a visual dart-board scale with 1 indicating perfect success, and 14 indicates being unsuccessful.
Range for each domain is 1 - 14 with lower as better outcome.
|
Baseline, post-treatment (8 weeks)
|
|
Valued Living - Leisure Domain
Time Frame: Baseline, post-treatment (8 weeks)
|
The Bulls-Eye Values measure assesses how successfully participants are at living in line with 4 domains of personal values (relationships, leisure, health, and work) on a visual dart-board scale with 1 indicating perfect success, and 14 indicates being unsuccessful.
Range for each domain is 1 - 14 with lower as better outcome.
|
Baseline, post-treatment (8 weeks)
|
|
Valued Living -Relationship Domain
Time Frame: Baseline, post-treatment (8 weeks)
|
The Bulls-Eye Values measure assesses how successfully participants are at living in line with 4 domains of personal values (relationships, leisure, health, and work) on a visual dart-board scale with 1 indicating perfect success, and 14 indicates being unsuccessful.
Range for each domain is 1 - 14 with lower as better outcome.
|
Baseline, post-treatment (8 weeks)
|
|
Valued Living -Work/Community Domain
Time Frame: Baseline, post-treatment (8 weeks)
|
The Bulls-Eye Values measure assesses how successfully participants are at living in line with 4 domains of personal values (relationships, leisure, health, and work) on a visual dart-board scale with 1 indicating perfect success, and 14 indicates being unsuccessful.
Range for each domain is 1 - 14 with lower as better outcome.
|
Baseline, post-treatment (8 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jennifer Plumb Vilardaga, PhD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00108300
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Adapted-Engage-PA
-
Duke UniversityNational Institute on Aging (NIA)CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
University of AlbertaAlberta Health servicesRecruitingNeurodevelopmental DisordersCanada
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
Uniformed Services University of the Health SciencesMassachusetts General Hospital; Beth Israel Deaconess Medical Center; University... and other collaboratorsRecruitingMental Health | Resilience | Risk Reduction Behavior | Suicide Prevention | Performance at Work | Risky BehaviorUnited States
-
Mental Health Services in the Capital Region, DenmarkCNSR, Glostrup Psychiatric CenterCompletedSchizophrenia Spectrum Disorders | Negative Symptoms in SchizophreniaDenmark
-
University of Nevada, Las VegasRecruitingMild Cognitive Impairment | Executive Dysfunction | Psychotherapy | Depression in Old AgeUnited States
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
University of PittsburghNational Center for Advancing Translational Sciences (NCATS)Terminated
-
University of MichiganCompletedKnee OsteoarthritisUnited States